Combining drugs that target AXL and ErbB receptors could offer better way to fight tu

[News]

Cancer drugs known as ErbB inhibitors have shown great success in treating many patients with lung, breast, colon and other types of cancer. However, ErbB drug resistance means that many other patients do not respond, and even among those who do, tumors commonly come back.

More... (http://www.news-medical.net/news/20130807/Combining-drugs-that-target-AXL-and-ErbB-receptors-could-offer-better-way-to-fight-tumors.aspx)